MOACM
ARRY

Mutual of America Capital Management’s Array Biopharma Inc ARRY Stock Holding History

Mutual of America Capital Management’s Portfolio ARRY Stock Details ARRY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q3 		– Sell
-179,501
Closed -$8.32M – 1720
2019
Q2 		$8.32M Buy
179,501
+117
+0.1% +$3.29K 0.12% 173
2019
Q1 		$4.37M Buy
179,384
+33,456
+23% +$697K 0.06% 456
2018
Q4 		$2.08M Hold
145,928
– – 0.03% 781
2018
Q3 		$2.22M Sell
145,928
-1,072
-0.7% -$16.4K 0.03% 856
2018
Q2 		$2.47M Buy
+147,000
New +$2.34M 0.04% 785

Other funds holding ARRY

ASN
Advisory Services Network Atlanta, Georgia $8.83B AUM 38.5% 1-Year Est. Return

Mutual of America Capital Management's ARRY Position: Q3 2019 in Review

Mutual of America Capital Management sold out of Array Biopharma Inc (ARRY) in Q3 2019, closing a stake of 179,501 shares — an estimated $8.32M sold.

Mutual of America Capital Management first reported a position in ARRY in Q2 2018 and held it in 5 quarters. The position peaked at $8.32M in Q2 2019. 1 fund tracked by Wall St. Rank holds ARRY as of Q3 2019.

  • Mutual of America Capital Management reported no remaining Array Biopharma Inc position as of Q3 2019 after selling out during the quarter.
  • Mutual of America Capital Management sold 179,501 Array Biopharma Inc shares in Q3 2019, an estimated $8.32M.
  • Mutual of America Capital Management first reported a position in Array Biopharma Inc in Q2 2018 and held it in 5 quarters.
  • Mutual of America Capital Management's Array Biopharma Inc position peaked at $8.32M in Q2 2019.
  • 1 fund tracked by Wall St. Rank held Array Biopharma Inc as of Q3 2019.

Based on Mutual of America Capital Management's 13F filing for Q3 2019, filed 14 Nov 2019.